• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

垂直感染的无症状或轻症未治疗儿童的HIV-1病毒载量和CD4细胞计数。欧洲儿科艾滋病治疗网络(PENTA)。

HIV-1 viral load and CD4 cell count in untreated children with vertically acquired asymptomatic or mild disease. Paediatric European Network for Treatment of AIDS (PENTA).

出版信息

AIDS. 1998 Mar 5;12(4):F1-8.

PMID:9520161
Abstract

BACKGROUND

Plasma HIV-1 RNA levels are high in vertically infected infants. Information in older children is limited, particularly in those who have not received antiretroviral therapy.

OBJECTIVES

To describe the relationships between HIV-1 RNA, age and CD4 cell count in untreated vertically infected children.

DESIGN

HIV-1 RNA was measured in 70 children [median age, 3.5 years (range, 0.4-11.9 years); median CD4 cell count, 881 x 10(6)/l (interquartile range, 576-1347 x 10(6) cells/l)] enrolled in a randomized placebo-controlled trial comparing immediate with deferred zidovudine in asymptomatic or mildly symptomatic vertically infected children (PENTA-1 trial). Short-term variability was assessed by comparing HIV-1 RNA at -2 and 0 weeks (prior to randomization). The relationship between age and HIV-1 RNA, and CD4 cell count was analysed using data from all children prior to randomization and sequential samples from 35 remaining on placebo for up to 105 weeks, by fitting mixed linear models.

RESULTS

The within-individual SD in viral load was 0.26 log10 copies/ml. The median plasma HIV-1 RNA at enrollment was 4.61 log10 (range, 2.3-6.56 log10 copies/ml), significantly higher in children aged < or = 2 years (median, 5.23 log10 copies/ml) than in those aged > 2 years (4.51 log10 copies/ml; P < 0.0001). Mean HIV-1 RNA fell by 0.38 log10 copies/ml per year up to 2 years of age, by 0.21 log10 copies/ml per year from 2 to 4 years of age, and by 0.03 log10 copies/ml per year from 4 to 6 years of age reaching a nadir of 4.25 log10 copies/ml at 6 years. Mean log10 CD4 cell count declined steadily with age and was not significantly correlated with HIV-1 RNA, although there was some evidence that the rate of log10 CD4 cell decline was negatively correlated with the initial rate of HIV-1 RNA decline. No mutations associated with resistance to zidovudine were observed.

CONCLUSIONS

Age is a key factor in the interpretation of both viral load and CD4 cell count in vertically infected children.

摘要

背景

垂直感染的婴儿血浆中HIV-1 RNA水平较高。关于大龄儿童的相关信息有限,尤其是那些未接受抗逆转录病毒治疗的儿童。

目的

描述未经治疗的垂直感染儿童中HIV-1 RNA、年龄和CD4细胞计数之间的关系。

设计

在一项随机安慰剂对照试验中,对70名儿童[中位年龄3.5岁(范围0.4 - 11.9岁);中位CD4细胞计数881×10⁶/l(四分位间距576 - 1347×10⁶细胞/l)]进行了HIV-1 RNA检测,该试验比较了无症状或症状轻微的垂直感染儿童立即使用齐多夫定与延迟使用齐多夫定的效果(PENTA-1试验)。通过比较随机分组前 -2周和0周时的HIV-1 RNA评估短期变异性。使用随机分组前所有儿童的数据以及35名继续使用安慰剂长达105周的儿童的序贯样本,通过拟合混合线性模型分析年龄与HIV-1 RNA以及CD4细胞计数之间的关系。

结果

病毒载量的个体内标准差为0.26 log₁₀拷贝/ml。入组时血浆HIV-1 RNA的中位数为4.61 log₁₀(范围2.3 - 6.56 log₁₀拷贝/ml),≤2岁儿童(中位数5.23 log₁₀拷贝/ml)显著高于>2岁儿童(4.51 log₁₀拷贝/ml;P<0.0001)。在2岁之前,HIV-1 RNA平均每年下降0.38 log₁₀拷贝/ml,2至4岁时每年下降0.21 log₁₀拷贝/ml,4至6岁时每年下降0.03 log₁₀拷贝/ml,6岁时达到最低点4.25 log₁₀拷贝/ml。平均log₁₀CD⁴细胞计数随年龄稳步下降,与HIV-1 RNA无显著相关性,尽管有一些证据表明log₁₀CD⁴细胞下降速率与HIV-1 RNA初始下降速率呈负相关。未观察到与齐多夫定耐药相关的突变。

结论

年龄是解释垂直感染儿童病毒载量和CD4细胞计数的关键因素。

相似文献

1
HIV-1 viral load and CD4 cell count in untreated children with vertically acquired asymptomatic or mild disease. Paediatric European Network for Treatment of AIDS (PENTA).垂直感染的无症状或轻症未治疗儿童的HIV-1病毒载量和CD4细胞计数。欧洲儿科艾滋病治疗网络(PENTA)。
AIDS. 1998 Mar 5;12(4):F1-8.
2
A randomized double-blind trial of the addition of lamivudine or matching placebo to current nucleoside analogue reverse transcriptase inhibitor therapy in HIV-infected children: the PENTA-4 trial. Paediatric European Network for Treatment of AIDS.在感染HIV的儿童中,于当前核苷类逆转录酶抑制剂治疗基础上加用拉米夫定或匹配安慰剂的随机双盲试验:PENTA-4试验。欧洲儿科艾滋病治疗网络
AIDS. 1998 Oct 1;12(14):F151-60.
3
Maternal viral load, zidovudine treatment, and the risk of transmission of human immunodeficiency virus type 1 from mother to infant. Pediatric AIDS Clinical Trials Group Protocol 076 Study Group.母亲的病毒载量、齐多夫定治疗与人类免疫缺陷病毒1型母婴传播风险。儿童艾滋病临床试验组方案076研究小组。
N Engl J Med. 1996 Nov 28;335(22):1621-9. doi: 10.1056/NEJM199611283352201.
4
The safety profile and antiviral activity of the combination of stavudine, didanosine, and nelfinavir in patients with HIV infection.司他夫定、去羟肌苷和奈非那韦联合用药在HIV感染患者中的安全性及抗病毒活性
Clin Ther. 1999 Nov;21(11):1853-63. doi: 10.1016/S0149-2918(00)86733-8.
5
A trial of three antiretroviral regimens in HIV-1-infected children.一项针对感染HIV-1的儿童的三种抗逆转录病毒治疗方案的试验。
N Engl J Med. 2004 Jun 10;350(24):2471-80. doi: 10.1056/NEJMoa032706.
6
AVANTI 2. Randomized, double-blind trial to evaluate the efficacy and safety of zidovudine plus lamivudine versus zidovudine plus lamivudine plus indinavir in HIV-infected antiretroviral-naive patients.阿凡提2. 一项随机、双盲试验,旨在评估齐多夫定加拉米夫定与齐多夫定加拉米夫定加茚地那韦在未接受过抗逆转录病毒治疗的HIV感染患者中的疗效和安全性。
AIDS. 2000 Mar 10;14(4):367-74.
7
Impact of drug resistance genotypes on CD4+ counts and plasma viremia in heavily antiretroviral-experienced HIV-infected patients.耐药基因型对接受大量抗逆转录病毒治疗的HIV感染患者CD4+细胞计数和血浆病毒血症的影响。
J Med Virol. 2005 Sep;77(1):23-8. doi: 10.1002/jmv.20395.
8
Mutations linked to drug resistance, human immunodeficiency virus type 1 biologic phenotype and their association with disease progression in children receiving nucleoside reverse transcriptase inhibitors.与耐药性、1型人类免疫缺陷病毒生物学表型相关的突变及其与接受核苷类逆转录酶抑制剂治疗的儿童疾病进展的关联。
Pediatr Infect Dis J. 2004 Jan;23(1):15-22. doi: 10.1097/01.inf.0000105105.80229.ba.
9
Effect of antiretroviral triple combinations including the protease inhibitor nelfinavir in heavily pretreated children with HIV-1 infection.包含蛋白酶抑制剂奈非那韦的抗逆转录病毒三联疗法对接受过大量治疗的HIV-1感染儿童的影响。
Eur J Med Res. 2002 Jul 24;7(7):330-4.
10
Maternal 12-month response to antiretroviral therapy following prevention of mother-to-child transmission of HIV type 1, Ivory Coast, 2003-2006.2003 - 2006年,科特迪瓦,预防1型艾滋病毒母婴传播后母亲接受抗逆转录病毒治疗的12个月反应情况
Clin Infect Dis. 2008 Feb 15;46(4):611-21. doi: 10.1086/526780.

引用本文的文献

1
Treatment outcomes among children younger than five years living with HIV in rural Zambia, 2008-2018: a cohort study.2008 - 2018年赞比亚农村地区感染艾滋病毒的5岁以下儿童的治疗结果:一项队列研究
BMC Pediatr. 2021 Jul 14;21(1):315. doi: 10.1186/s12887-021-02793-y.
2
Predictors of virologic and clinical response to nevirapine versus lopinavir/ritonavir-based antiretroviral therapy in young children with and without prior nevirapine exposure for the prevention of mother-to-child HIV transmission.在预防母婴传播艾滋病毒方面,接受奈韦拉平与洛匹那韦/利托那韦为基础的抗逆转录病毒疗法的幼儿,无论之前是否接触过奈韦拉平,其病毒学和临床反应的预测因素。
Pediatr Infect Dis J. 2014 Aug;33(8):846-54. doi: 10.1097/INF.0000000000000337.
3
A new tool for the paediatric HIV research: general data from the Cohort of the Spanish Paediatric HIV Network (CoRISpe).
一种新的儿科 HIV 研究工具:西班牙儿科 HIV 网络队列(CoRISpe)的一般数据。
BMC Infect Dis. 2013 Jan 2;13:2. doi: 10.1186/1471-2334-13-2.
4
Risk of triple-class virological failure in children with HIV: a retrospective cohort study.HIV 儿童发生三药耐药的风险:一项回顾性队列研究。
Lancet. 2011 May 7;377(9777):1580-7. doi: 10.1016/S0140-6736(11)60208-0. Epub 2011 Apr 20.
5
Mother-to-infant transmission of simian immunodeficiency virus is rare in sooty mangabeys and is associated with low viremia.在黑长尾猴中,母婴间猴免疫缺陷病毒传播罕见,与低病毒血症相关。
J Virol. 2011 Jun;85(12):5757-63. doi: 10.1128/JVI.02690-10. Epub 2011 Mar 30.
6
Viral load, CD4+ T-lymphocyte counts and antibody titres in HIV-1 infected untreated children in Kenya; implication for immunodeficiency and AIDS progression.肯尼亚未接受治疗的HIV-1感染儿童的病毒载量、CD4+T淋巴细胞计数及抗体滴度;对免疫缺陷和艾滋病进展的影响
Afr Health Sci. 2006 Mar;6(1):3-13. doi: 10.5555/afhs.2006.6.1.3.
7
Zidovudine: a review of its use in the management of vertically-acquired pediatric HIV infection.齐多夫定:关于其在垂直传播的儿童HIV感染管理中的应用综述。
Paediatr Drugs. 2002;4(8):515-53. doi: 10.2165/00128072-200204080-00004.
8
Viral Load Monitoring in HIV Infection.HIV感染中的病毒载量监测
Curr Infect Dis Rep. 1999 Dec;1(5):497-503. doi: 10.1007/s11908-999-0064-9.
9
Dynamics of human immunodeficiency virus type 1 replication in vertically infected infants.1型人类免疫缺陷病毒在垂直感染婴儿体内的复制动态
J Virol. 1999 Jan;73(1):362-7. doi: 10.1128/JVI.73.1.362-367.1999.